Keywords:
Enhancement, Psychotropic drugs, Responsibility, Posthuman, TranshumanismAbstract
Improving human condition can be a dream or a nightmare. Current techniques, especially pharmacological ones, which are beginning to become available, raise important ethical problems. Many of their promises force us to think about whether it is desirable to reach the goal of the posthuman, a sort of improved human whose characteristics are so far removed from the existing human that it is practically unimaginable. The question is whether there is a single model of improvement, whether we are seeking to alter our capacities to achieve new accomplishments or whether we are aspiring to configure a new way of being, if by doing so we will generate greater inequalities and injustices. The analysis of the arguments of this debate is the object of this text whose conclusion cannot be other than the call for responsibility in decisions about our future as human beings.
Downloads
References
BENSON, K., FLORY, K., HUMPHREYS, K.L. Y LEE, S.S. (2015). Misuse of stimulant medication among college students: a comprehensive review and meta-analysis. Clinical Child and Family Psychology Review, 18(1), 50–76. https://doi.org/10.1007/s10567-014-0177-z
BUTCHER, J. (2003). Cognitive Enhancement Raises Ethical Concerns. Lancet, 362(9378), 132–133. https://doi.org/10.1016/s0140-6736(03)13897-4
BOSTROM, N. (2003). Transhumanist Values. En F. Adams (Ed.), Ethical Issues for the 21st Century. Philosophical Documentation Center Press.
CAKIC V. (2009). Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. Journal of Medical Ethics, 35(10), 611–615. https://doi.org/10.1136/jme.2009.030882
CAPLAN, A. (2003). Is Better Best? A Noted Ethicist Argues in Favor of Brain Enhancement. Scientific American, 289(3), 104?105
CENTER FOR COGNITIVE LIBERTY & ETHICS (CCLE). (2003). General Info. Center for Cognitive Liberty and Ethics. Recuperado el 8 de noviembre de 2020 de: https://www.cognitiveliberty.org/ccle1/faqs/faq_general.htm
CHIAO, J.Y. (2010). At the frontier of cultural neuroscience: introduction to the special issue. Social Cognitive and Affective Neuroscience, 5(2-3), 109–110. https://doi.org/10.1093/scan/nsq064
CHIAO, J.Y. Y BEBKO, G.M. (2011). Cultural Neuroscience of Social Cognition. En S. Han y E. Pöppel (Eds.), Culture and Neural Frames of Cognition and Communication. Springer-Verlag.
DEGRAZIA, D. (2013). Moral enhancement, freedom, and what we (should) value in moral behaviour. Journal of Medical Ethics, 40(6), 361–368. https://doi.org/10.1136/medethics-2012-101157
DIÉGUEZ, A. (2017). Transhumanismo. La búsqueda tecnológica del mejoramiento humano. Herder.
FM-2030. (1989). Are You a Transhuman?. Warner Books.
GREELY, H., SAHAKIAN, B., HARRIS, J. ET AL. (2008). Toward Responsible Use of Cognitive-Enhancing Drugs by the Healthy. Nature, 456 (7223), 702–705. https://doi.org/10.1038/456702a
HEALY, D. (2000). Good Science or Good Business?. Hastings Center Report, 30(2), 19–22. https://doi.org/10.2307/3528308
KRAMER, P. (1994). Escuchando al Prozac. Seix Barral.
MACLAREN, E. (2019). History and statistics of “study drugs”. Recuperado el 8 de noviembre de 2020 de: https://drugabuse.com/adderall/history-and-statistics-of-study-drugs/
MEHLMAN, M.J. (2004). Cognition-Enhancing Drugs. Milbank Quarterly, 82(3), 483–506. https://doi.org/10.1111/j.0887-378X.2004.00319.x
PRESIDENT'S COUNCIL ON BIOETHICS (2003). Beyond Therapy: Biotechnology and the Pursuit of Happiness. Recuperado el 8 de noviembre de 2020 de: http://bioethics.georgetown.edu/pcbe/reports/beyondtherapy/beyond_therapy_final_webcorrected.pdf
SANDEL, M. (2007). Contra la perfección. La ética en la era de la ingeniería genética. Marbot.
SAVULESCU, J. (2012) ¿Decisiones peligrosas? Una bioética desafiante. Tecnos.